PlainRecalls

Annora Pharma Private Limited

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Jul 1, 2026

Subscribe to new Annora Pharma Private Limit… recalls (RSS)

Agency notice ledger

Federal filing book Annora Pharma Private Limit… LIGHT-BOOK · SINGLE-AGENCY

#4,345 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #4,345 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT drugs
  • CATS 1 category
  • LATEST Jul 1, 2026
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Annora Pharma Private Limited accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Annora Pharma Private Limit…'s standing among 14,151 recalling firms

Annora Pharma Private Limited ranks 4,345th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Annora Pharma Private Limit… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 4345th of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-15

Annora Pharma Private Limit… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Annora Pharma Private Limited holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Jul 1, 2026

Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
FDA Drug Low Mar 25, 2026

Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Pharma Pvt. LTd., Sengareddy - 502313, Telengana, India, NDC 72603-479-01.

Annora Pharma Private Limit… is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Annora Pharma Private Limit…? ▼
PlainRecalls indexes 2 distinct federal recall events naming Annora Pharma Private Limited, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Annora Pharma Private Limit… sit among other recalling firms? ▼
Annora Pharma Private Limited ranks #4,345 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Annora Pharma Private Limit…'s notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Annora Pharma Private Limit…'s filing book? ▼
Filings for Annora Pharma Private Limited span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Annora Pharma Private Limited: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Annora Pharma Private Limited; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026